Tagged with Medicine

3 Key Takeaways from Europe’s Premier Regulatory Conference
EMA 2023 New Drug Approvals: Cancer at the Forefront
Belgium’s EU Council Presidency Priorities for Healthcare & Pharma
4 Portugal Pharma Country Managers On Access to Innovation Challenges
Filipa Mota e Costa – Managing Director, Johnson & Johnson Innovative Medicine
How to Boost Europe’s Strategic Autonomy in Medicines?
Elisabeth Stampa – President, Medicines for Europe
EU Acts on the Promise of Artificial Intelligence for Medicinal Products
Access to Medicine Index 2024 to Prioritise ‘Patient Reach’
A European Approach to Enable Equal Access to Precision Oncology
The African Medicines Agency and the Evolution of Continental Regulatory Systems
4 Key Priorities for the European Medicines Agency in 2023
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here